Stay updated on Nivolumab for Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Hematologic Malignancies Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:22:37.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    2%
    Check dated 2025-08-01T18:48:39.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.3%
    Check dated 2025-07-25T12:08:42.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.1%
    Check dated 2025-07-18T10:41:47.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page now includes a service alert about planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours. Additionally, the version has been updated from v2.16.4 to v2.16.5.
    Difference
    4%
    Check dated 2025-07-11T03:54:42.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    2%
    Check dated 2025-06-19T19:23:08.000Z thumbnail image

Stay in the know with updates to Nivolumab for Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Hematologic Malignancies Clinical Trial page.